Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression

Prostate cancer is a heterogeneous disease. MiR-375 is a marker for prostate cancer progression, but its cellular function is not characterized. Here, we provide the first comprehensive investigation of miR-375 in prostate cancer. We show that miR-375 is enriched in prostate cancer compared to norma...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncotarget
Huvudupphovsmän: Pickl, Julia M.A., Tichy, Diana, Kuryshev, Vladimir Y., Tolstov, Yanis, Falkenstein, Michael, Schüler, Julia, Reidenbach, Daniel, Hotz-Wagenblatt, Agnes, Kristiansen, Glen, Roth, Wilfried, Hadaschik, Boris, Hohenfellner, Markus, Duensing, Stefan, Heckmann, Doreen, Sültmann, Holger
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2016
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5312160/
https://ncbi.nlm.nih.gov/pubmed/27449098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10729
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk